Match!
Triana Lobatón
Bellvitge University Hospital
Inflammatory bowel diseaseUlcerative colitisDiabetes mellitusMedicineGastroenterology
37Publications
11H-index
442Citations
What is this?
Publications 39
Newest
#1Anneline CremerH-Index: 3
#2Triana LobatónH-Index: 11
Last. Denis FranchimontH-Index: 47
view all 29 authors...
Source
#2Jean-Frederic Colombel (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 129
Last. Jean-François RahierH-Index: 16
view all 12 authors...
Source
#1F Cañete (Autonomous University of Barcelona)H-Index: 3
#2Míriam MañosaH-Index: 24
Last. Eugeni DomènechH-Index: 30
view all 9 authors...
Purpose Nivolumab, a monoclonal antibody-targeting programmed cell death protein-1, is being increasingly used for the treatment of some advanced neoplasms. Several of its adverse effects are a result of the upregulation of T cells, with colitis as one of the most severe, and a challenging differential diagnosis with ulcerative colitis. However, few real-life clinical practice cases have been reported beyond trials. Our aim was to report a series of new cases, reviewing previously communicated e...
Source
#1Yamile ZabanaH-Index: 16
#2Lorena RodríguezH-Index: 4
Last. Maria EsteveH-Index: 26
view all 17 authors...
1 CitationsSource
#1Jordi Guardiola (University of Barcelona)H-Index: 24
#2Triana LobatónH-Index: 11
Last. Francisco Rodriguez-Moranta (University of Barcelona)H-Index: 22
view all 9 authors...
Abstract The management of inflammatory bowel disease (IBD) is currently based on the objective evaluation of intestinal lesions. It would therefore be interesting to have access to simple and non-invasive tools to monitor IBD activity and to identify the presence of lesions. Faecal calprotectin (FC) is the main cytosolic protein of neutrophils, it is resistant to bacterial degradation and it is stable at room temperature for several days, characteristics that make it suitable for use in clinica...
1 CitationsSource
#1Jordi Guardiola (University of Barcelona)H-Index: 24
#2Triana LobatónH-Index: 11
Last. Francisco Rodriguez-Moranta (University of Barcelona)H-Index: 22
view all 9 authors...
Resumen Actualmente, el manejo de la enfermedad inflamatoria intestinal (EII) se basa en la evaluacion objetiva de las lesiones intestinales. Por ello, es de interes disponer de herramientas sencillas y no invasivas con las que monitorizar la actividad de la EII e identificar la presencia de lesiones. La calprotectina fecal (CF) constituye la principal proteina citosolica de los neutrofilos, es resistente a la degradacion bacteriana y estable a temperatura ambiente durante dias, caracteristicas ...
4 CitationsSource
#1Daniel AzuaraH-Index: 10
#2Susanna AussóH-Index: 3
Last. Javier de OcaH-Index: 15
view all 13 authors...
2 CitationsSource
#1P TorresH-Index: 1
#2Triana LobatónH-Index: 11
Last. Eugeni DomènechH-Index: 30
view all 7 authors...
Source
#1F CañeteH-Index: 3
#2Triana LobatónH-Index: 11
Last. E. DomènechH-Index: 5
view all 10 authors...
Source
#1M CalafatH-Index: 4
#2Triana LobatónH-Index: 11
Last. Eugeni DomènechH-Index: 30
view all 8 authors...
Abstract Background Ulcerative proctitis (UP) presents distinctive clinical characteristics, outcomes and therapeutic approaches as compared to left-sided and extensive ulcerative colitis (UC). Aim To describe the current therapeutic requirements and clinical outcomes in patients with active UP. Methods Retrospective observational study conducted in a referral IBD centre. Patients with UP in follow-up between 1989 and 2014 were included. The clinical characteristics, as well as the different tre...
1 CitationsSource
1234